Antelope, O., Vellore, N., Pomicter, A. D., Patel, A. B., van Scoyk, A., Clair, P. M., . . . O’Hare, T. (2019). BCR-ABL1 tyrosine kinase inhibitor K0706 exhibits pre-clinical activity in Philadelphia chromosome-positive leukemia. Exp Hematol.

Antelope, Orlando, Nadeem Vellore, Anthony D. Pomicter, Ami B. Patel, Alexandria van Scoyk, Phillip M. Clair, Michael Deininger, and Thomas O’Hare. "BCR-ABL1 Tyrosine Kinase Inhibitor K0706 Exhibits Pre-clinical Activity in Philadelphia Chromosome-positive Leukemia." Exp Hematol 2019.

Antelope, Orlando, et al. "BCR-ABL1 Tyrosine Kinase Inhibitor K0706 Exhibits Pre-clinical Activity in Philadelphia Chromosome-positive Leukemia." Exp Hematol 2019.